DuLac Farmaceutici Accelerates U.S. Expansion with OneLavi Launch and ECRM Participation

DuLac Farmaceutici is accelerating its push into the U.S. market, announcing that its Italian-developed products are now available through OneLavi.com as the company prepares to participate in the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, September 14-17 in Palm Beach Gardens, Florida.

The two developments represent important steps in DuLac's strategy to significantly expand its presence in the United States. After establishing consumer demand through Amazon U.S., the Italian pharmaceutical company is adding a new e-commerce channel while preparing to introduce its brand and product portfolio to major U.S. retailers participating at ECRM.

DuLac sees the United States as a significant long-term growth market and is approaching its expansion accordingly.

Rather than relying on a single sales channel, the company is building a broader U.S. presence that combines established Amazon demand, expanded e-commerce availability through OneLavi, and direct engagement with retailers and distribution partners.

"ECRM comes at an important time for DuLac because we are making a major commitment to the U.S. market," said Gabriele Bollani, Founder and CEO of DuLac Farmaceutici. "Amazon has demonstrated that American consumers are responding to our products, OneLavi gives us another important U.S. channel, and now we are ready to introduce DuLac to major retailers and build the partnerships that can take our expansion to the next level."

DuLac enters this next phase with an established base of U.S. consumer demand.

Consumer response on Amazon continues to underscore DuLac's growing presence in the U.S. market, with Arnica Gel 98% earning more than 13,000 customer reviews and an average 4.5-star rating, while the company's Dinaven line has received more than 4,000 customer reviews and maintains an average 4.6-star rating.

The addition of OneLavi represents the next step in broadening that footprint. DuLac products are now available to OneLavi customers, giving the company another platform through which to introduce its Made in Italy portfolio to American consumers.

DuLac's participation at ECRM adds an important business-to-business dimension to the company's U.S. expansion.

During the 2026 ECRM Vitamin, Weight Management & Sports Nutrition Session, DuLac will participate in scheduled meetings with buyers representing major health, specialty, food, drug, and mass retail channels, providing an opportunity to introduce the company's Italian-developed product portfolio, pharmaceutical heritage, and advanced manufacturing capabilities to potential U.S. retail partners.

Among the portfolio DuLac will highlight are its high-concentration Arnica Gel 98% range and the Dinaven and Diosmin lines.

For DuLac, the objective extends beyond gaining additional points of distribution. The company is using ECRM to establish relationships that can support a much larger and more diversified U.S. retail presence as it moves forward with its national expansion strategy.

DuLac brings more than 30 years of pharmaceutical industry expertise and pharmacy-channel experience in Italy to its U.S. expansion.

The company's product development and manufacturing capabilities include its proprietary Arnica Montana Arricchita™ project, indoor vertical farming, micronized Diosmin MPFF technology, solvent-free Supercritical CO₂ Extraction, and manufacturing under internationally recognized GMP and ISO quality frameworks.

This combination of Italian pharmaceutical heritage, research, advanced production technologies, established Amazon consumer demand, and growing U.S. distribution provides the foundation for DuLac's next stage of growth.

With Amazon already established, OneLavi now live, and scheduled meetings with major retail buyers planned through ECRM, DuLac is moving from initial U.S. market development toward a broader national expansion strategy.

The company's goal is to build a diversified U.S. presence across e-commerce, retail, wholesale, and other distribution channels while introducing more American consumers to the DuLac brand and its Italian-developed product portfolio.

DuLac Farmaceutici is an Italian wellness company specializing in dermocosmetic, recovery-focused, and circulation-support products developed through pharmaceutical-grade manufacturing standards. Built on more than 30 years of pharmaceutical industry expertise, the company combines botanical innovation, advanced extraction technologies, and modern manufacturing to create wellness solutions designed for active lifestyles and everyday well-being. DuLac products are developed and manufactured in Italy using rigorous quality and sustainability standards. Learn more at DuLac Farmaceutici USA and through the company’s Amazon Storefront and on One Lavi.

This contant was orignally distributed by Newsworthy.ai. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is DuLac Farmaceutici Accelerates U.S. Expansion with OneLavi Launch and ECRM Participation.